Can fasting help treat cancer?

Can fasting help treat cancer? This question has attracted increasing attention because researchers are investigating whether changes in nutrition and metabolism could influence cancer treatment.

However, the fact that fasting is being studied does not mean it is an established or recommended cancer therapy.

The Claim: Can Fasting Help Treat Cancer?

Fasting before or during cancer treatment can help treat cancer, make cancer cells more vulnerable to treatment, or reduce the side effects of chemotherapy.

Versions of this claim appear frequently online. Some go further, suggesting that fasting can “starve” cancer or that patients should deliberately stop eating around chemotherapy.

The Short Answer

Fasting is being studied in cancer treatment, but current human evidence does not establish that fasting treats cancer, improves survival, makes chemotherapy more effective or reliably reduces treatment side effects.

Many patients ask whether fasting can help treat cancer, especially during chemotherapy. Researchers are studying this possibility, but there is currently insufficient clinical evidence that fasting improves cancer survival or treatment outcomes.

Laboratory and animal studies have produced interesting findings about fasting, metabolism and cellular stress. Small human studies have also tested short periods of fasting around chemotherapy.

The problem is that clinical studies are still generally small and use different fasting schedules, cancer types and treatments. That makes it difficult to know whether fasting provides a meaningful benefit to patients.

What Does the Evidence Say About Fasting and Cancer?

A systematic review of fasting during cancer treatment examined nine publications representing eight studies and 379 patients. Most participants had breast or gynecological cancers.

The fasting protocols differed substantially. Patients fasted for different lengths of time before, during or after treatment, and the studies were generally small.

The review found that the available research was not strong enough to establish a clear clinical benefit.

Some individual studies have reported potentially favorable effects on certain symptoms or measures of treatment tolerance. But results have not been consistent enough to establish fasting as a useful cancer intervention.

This distinction matters. Something can be promising enough to study without being proven to help patients.

Can Fasting Make Chemotherapy Work Better?

At present, there is no strong clinical evidence showing that fasting makes chemotherapy more effective in people with cancer.

Researchers have proposed that fasting could change glucose, insulin, growth signaling and cellular stress responses.

In laboratory models, these changes may affect cancer cells and normal cells differently.

That is an interesting biological hypothesis. But it has not yet translated into convincing evidence that patients who fast have better cancer outcomes.

Does Fasting Reduce Chemotherapy Side Effects?

This is another major reason fasting has attracted scientific attention.

One hypothesis is that healthy cells may respond differently to temporary nutrient restriction than cancer cells.

Small clinical studies have explored outcomes such as fatigue, nausea, quality of life and chemotherapy toxicity.

Some findings have been encouraging, while others have not shown a clear advantage.

Overall, the evidence is still insufficient to say that fasting reliably protects patients from chemotherapy side effects.

Where Did the Fasting and Cancer Claim Come From?

The idea that fasting could affect cancer did not come from nowhere.

Laboratory and animal research has suggested that restricting nutrients can alter metabolic pathways involved in cell growth and stress responses.

Researchers have investigated whether these changes might make cancer cells more vulnerable to treatment while helping normal cells tolerate stress.

This research has led scientists to investigate several approaches in humans:

• Short-term fasting before chemotherapy
• Fasting during or shortly after chemotherapy
• Time-restricted eating
• Fasting-mimicking diets
• Other forms of temporary calorie restriction

These approaches are not the same. A shorter overnight eating window is very different from going one or more days with little or no food.

Differences like these make the research harder to compare.

Is Fasting Still Being Studied in People With Cancer?

Yes. Human trials continue to investigate whether carefully controlled fasting or time-restricted eating may be useful during cancer treatment.

For example, the registered clinical study NCT05259410 investigates time-restricted eating during chemotherapy in women with stage I–III breast cancer.

Studies like this are important because they test whether ideas generated by laboratory research translate into meaningful effects in patients.

Could Fasting During Cancer Treatment Be Harmful?

Yes. For some people undergoing cancer treatment, deliberately restricting food may create additional problems.

Cancer and its treatments can already make it difficult to maintain adequate nutrition.

Chemotherapy, radiation, surgery and the cancer itself may cause poor appetite, nausea, diarrhea, mouth sores, taste changes, swallowing problems or other difficulties with eating.

Adding fasting can make adequate calorie and protein intake even harder.

This is especially important because adequate nutrition and preservation of muscle mass can matter during cancer treatment.

ESPEN’s clinical nutrition guidance emphasizes identifying and treating nutritional problems in people with cancer.

A fasting strategy therefore needs to be considered in the context of the individual patient’s nutritional status, treatment and overall condition.

What Do We Still Not Know?

Fasting research in oncology is not finished. Larger, well-designed human trials still need to answer several important questions:

• Does fasting improve tumor response?
• Does it improve progression-free or overall survival?
• Can it meaningfully reduce treatment toxicity?
• Are certain cancers more likely to benefit?
• Does any effect depend on the treatment being used?
• What fasting schedule, if any, is safest?
• Which patients should specifically avoid fasting?

Until stronger evidence answers these questions, fasting should be considered an experimental nutritional strategy rather than an established cancer treatment.

Related CancerSnoop Articles

CancerSnoop Bottom Line

Scientific Sources

Questions for Your Doctor

If you are thinking about fasting during cancer treatment, useful questions to ask your cancer care team include: